Skip to main content
Icade logo

Icade — Investor Relations & Filings

Ticker · ICAD ISIN · FR0000035081 LEI · 969500UDH342QLTE1M42 PA Real estate activities
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2012-05-07 Share Issue/Capital Cha…
Country FR France
Listing PA ICAD

About Icade

https://www.icade.fr/en/

Icade is an integrated real estate company that operates as both a property investor and a property developer. The company's investment division focuses on a portfolio of commercial properties, including offices and business parks, as well as healthcare facilities. As a developer, Icade designs, builds, and manages a diverse range of assets, from residential properties to large-scale urban projects. A central element of its strategy is the creation of innovative and sustainable real estate solutions, with an emphasis on developing low-carbon buildings and functional urban spaces for future communities.

Recent filings

Filing Released Lang Actions
Icade : Nbre d'actions et de droits de vote au 30 avril 2012
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated May 7, 2012, titled 'Information mensuelle relative au nombre total d'actions et de droits de vote composant le capital' (Monthly information relating to the total number of shares and voting rights making up the capital). It explicitly references compliance with French regulatory articles (AMF and Code de commerce) and presents a table detailing the total number of shares and voting rights as of April 30, 2012. This type of regular disclosure regarding the capital structure and voting rights is a specific regulatory filing requirement in France, often related to changes in share capital or major holdings. While it is a monthly update, it is not a comprehensive financial report (10-K or IR). It most closely aligns with notifications concerning share capital structure or major shareholdings. Given the options, 'Major Shareholding Notification' (MRQ) covers changes in significant ownership levels, and while this is about the total capital base, it is a specific regulatory disclosure. However, since it is a mandatory monthly disclosure about the total share count and voting rights, it fits best under the general 'Regulatory Filings' (RNS) as a specific, non-financial periodic disclosure, or potentially 'Share Issue/Capital Change' (SHA) if the focus is strictly on the capital base count. Since it is a mandatory disclosure of the total capital and voting rights, which is a key component of major shareholding transparency, MRQ is a strong candidate, but RNS is the safest fallback for specific regulatory disclosures not covered elsewhere. Given the precise nature of the data (total shares/votes), and the lack of a specific 'Capital Structure Disclosure' code, I will classify it as a general Regulatory Filing (RNS) as it is a mandatory regulatory update that doesn't fit the other specific financial/event codes.
2012-05-07 French
Icade :The French stock market authority approves Icade's offer for Silic
M&A Activity Classification · 98% confidence The document is a press release announcing that the French stock market authority (AMF) has approved Icade's offer for Silic. This involves a share exchange offer and a tender offer for notes (ORNANEs). This activity directly relates to a proposal for a takeover or merger between two companies (Icade and Silic). According to the definitions, this falls under M&A Activity (TAR). The document is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but specifically details a takeover/merger proposal.
2012-04-26 English
Icade :L'AMF déclare conforme l'offre publique d'Icade sur Silic
M&A Activity Classification · 98% confidence The document is a press release dated April 26, 2012, announcing that the French financial market authority (Autorité des marchés financiers - AMF) has approved Icade's public offer (tender offer and exchange offer) for Silic shares and bonds. This announcement details the terms of a takeover bid (exchange ratio, cash offer price, offer period) and refers to the official documentation (note d'information). This clearly falls under the category of Merger & Acquisition (M&A) activity, specifically a takeover bid/proposal. The corresponding code is TAR (M&A Activity). The document length is relatively short (4003 chars) and functions as an announcement of the transaction terms, not the full regulatory filing itself.
2012-04-26 French
Icade : Offre publique d'Icade sur Silic
M&A Activity Classification · 99% confidence The document is a press release ('Communiqué de presse') dated April 26, 2012, detailing the terms of a Public Exchange Offer (Offre Publique d'Echange) for Silic shares and a Public Purchase Offer (Offre Publique d'Achat) for Silic bonds (ORNANES) by Icade. It explicitly mentions the AMF (Autorité des marchés financiers) visa and refers to the 'note d'information' (information note) related to the offer. This content directly relates to a takeover bid or merger proposal, which aligns with the definition of M&A Activity (TAR). Although it mentions the availability of the information note, the document itself is the announcement detailing the terms of the transaction, not just a generic report publication announcement (RPA).
2012-04-26 French
Icade : Ouverture du capital d'Icade Santé
Share Issue/Capital Change Classification · 99% confidence The document is titled "Ouverture du capital d'Icade Santé" (Opening of Icade Santé's capital) and explicitly states that Icade Santé is conducting a capital increase ("augmentation de capital") for €250 million, reserved for institutional investors. This action directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition of Capital/Financing Update (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2012-04-12 French
Icade : Opening of the share capital of Icade Santé
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing that Icade Santé is increasing its share capital by €250 million through a reserved capital increase involving institutional investors (Crédit Agricole Assurances and BNP Paribas Cardif). This action directly relates to changes in the company's capital structure and fundraising activities. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP), as it details a significant capital injection and resulting ownership structure change.
2012-04-12 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.